BNP PARIBAS FINANCIAL MARKETS - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,996
-85.7%
3,000
-83.3%
0.00%
Q1 2023$34,932
+3.9%
18,0000.0%0.00%
Q4 2022$33,625
-100.0%
18,000
-82.5%
0.00%
-100.0%
Q3 2022$8,988,096,000
+432.7%
102,976
-92.3%
0.01%
+366.7%
Q2 2022$1,687,256,000
-3.9%
1,337,0000.0%0.00%
+50.0%
Q1 2022$1,755,225,000
-85.4%
1,337,000
-83.8%
0.00%
-88.2%
Q4 2021$12,041,619,000
-29.7%
8,257,000
-28.6%
0.02%
-29.2%
Q3 2021$17,138,746,000
+178.9%
11,560,000
+148.1%
0.02%
+200.0%
Q2 2021$6,145,599,000
-34.8%
4,660,000
-35.2%
0.01%
-42.9%
Q1 2021$9,424,227,000
-59.1%
7,195,000
-23.5%
0.01%
-67.4%
Q4 2020$23,034,356,000
+197.7%
9,407,000
+151.7%
0.04%
+290.9%
Q3 2020$7,737,436,000
+93.3%
3,738,000
+115.1%
0.01%
+57.1%
Q2 2020$4,002,684,000
-10.8%
1,738,000
-41.3%
0.01%
-22.2%
Q1 2020$4,488,289,000
-64.9%
2,962,000
-49.0%
0.01%
-64.0%
Q2 2019$12,775,072,0005,803,0000.02%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 82,499,000$120,618,0003.75%
WOLVERINE ASSET MANAGEMENT LLC 76,497,000$112,118,0001.04%
Verition Fund Management LLC 24,689,000$36,219,0000.26%
Baker Brothers Advisors 29,174,000$42,695,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 6,858,000$10,032,0000.17%
LORD, ABBETT & CO. LLC 48,435,000$71,054,0000.16%
Calamos Advisors LLC 21,131,000$30,817,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 3,218,000$4,726,0000.10%
Point72 Asset Management, L.P. 9,507,000$13,948,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 10,000,000$14,609,0000.05%
View complete list of SAREPTA THERAPEUTICS INC shareholders